Subscribe Now According to GSK, this new investment will be utilized to bring state-of-the-art drug substance manufacturing ...

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...

Josh Shapiro’s administration, convinced GSK to choose Marietta over other sites for a new 270,000 ... vaccines and a new research facility manufacturing medicines for clinical trials.

Former Barrow and Furness MP Simon Fell chaired a taskforce which developed a vision for Ulverston Life Science and Advanced Manufacturing Park on the former GSK site, which had been tipped to create ...

In 2022, GSK’s 12 manufacturing sites in eight countries produced and delivered more than 500 million vaccine doses—one and a half million vaccine doses daily. Each year, about 40% of the ...

The company has had space in the complex since its 2012 acquisition of Human Genome Sciences. International drug giant GSK PLC is moving its vaccine R&D and infectious disease teams from Rockville ...

GSK (GlaxoSmithKline) is due to close its Ulverston factory in June, bringing to an end 75 years of history, and we’re remembering what ...

GSK was able to avert industrial action at some ... The Unite union, representing around 160 workers at the Montrose site, said the offer constitutes a “substantial real terms pay cut” given ...

Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline. It came as the boss of the London-listed firm cheered an "excellent" performance ...

Working out of 12 manufacturing sites, the company distributed 767 million vaccine doses across more than 160 countries in 2021. More than ten million people received one of GSK’s meningococcal ...